• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

4.680 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
March 16, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
March 13, 2026
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
March 12, 2026
From SciSparc Ltd
Via GlobeNewswire
Which stocks are moving on Tuesday? ↗
March 10, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
March 10, 2026
Via Chartmill
News headline image
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
March 10, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
March 10, 2026
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
SciSparc Announces 1-for-9 Reverse Share Split
March 02, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
February 02, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
January 26, 2026
From SciSparc Ltd
Via GlobeNewswire
Which stocks are moving after the closing bell on Wednesday? ↗
January 21, 2026
Via Chartmill
These stocks are gapping in today's session ↗
January 13, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
January 13, 2026
Via Chartmill
News headline image
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
January 13, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
January 12, 2026
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
December 30, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
December 26, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
December 05, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
December 02, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
December 01, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
November 26, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Wednesday's pre-market session: top gainers and losers ↗
November 26, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech ↗
November 26, 2025
In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company. 
Via Stocktwits
Topics Intellectual Property
News headline image
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
November 26, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
These stocks that are showing activity before the opening bell on Tuesday. ↗
November 25, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
November 20, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
November 17, 2025
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
October 24, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
October 23, 2025
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
October 23, 2025
From SciSparc Ltd
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap